LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2023

Jun 29, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2023-06-29

Reporting Person: COATS LONNEL (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-29	Common Stock	P	10000	$2.16	Acquired	814359	Direct